Analyst Ratings
Coinbase Could Be One of Crypto’s Long-Term Survivors: Oppenheimer
The investment giant’s senior analyst is relatively optimistic the crypto exchange could stick around after crypto’s ice age finally melts.

Coinbase Rally May Be a Selling Opportunity, Says Bank of America
Analyst Jason Kupferberg downgraded the crypto exchange to underperform from neutral, saying 2023 estimates are still too high.

Analysts ‘Encouraged’ by Coinbase Layoffs, Showing Company Is Being Financially Disciplined
The crypto exchange’s dwindling group of sell-side bulls said Tuesday’s announced staffing cuts are a necessary step.

Signature Bank Downgraded at Jefferies Due to Shrinking Crypto Business
The cut to "hold" by the formerly bullish analyst comes after the stock has suffered a 67% year-over-year decline.

Jefferies Initiates Coverage of Crypto Exchange Coinbase With ‘Hold’ Rating on Near-Term Concerns
The exchange has staying power due to its healthy balance sheet, a proactive approach to regulatory compliance, sensible risk management and legitimacy as a public company, the report said.

Citi Downgrades Robinhood, Says FTX Fallout Will Weigh on Crypto Trading Revenue
The bank downgraded the trading platform to neutral from buy, with a lowered price target of $10.

Crypto Bank Signature Suffers Another Analyst Downgrade; Shares Fall
Raymond James is the latest Wall Street firm to cut its rating on the stock, following Morgan Stanley’s move earlier this week.

Morgan Stanley rebaja la calificación de las acciones de Silvergate tras el colapso de FTX
Con bajas de más del 50% durante el mes pasado, las acciones del banco volvieron a caer otro 3% previo a la comercialización del lunes a la mañana.

Crypto Bank Silvergate Cut to Underweight at Morgan Stanley Following FTX Collapse
Already down more than 50% over the past month, the bank’s shares are lower by another 3% in premarket action Monday morning.

Bank of America Downgrades Crypto Exchange Coinbase to Neutral in FTX Aftermath
The bank had rated the shares at buy. It cut its price target to $50 from $77.
